Moreover, significantly increased phosphorylation of Smad3 and decreased phosphorylation of Smad1/5/9 were detected in MMC-treated rats and PAH patients, suggesting the imbalance of Smad pathways during the PAH process. This evidence concerns the gene SMAD1 and pulmonary arterial hypertension.